Cigna Group $CI Shares Sold by One Capital Management LLC

One Capital Management LLC lowered its position in shares of Cigna Group (NYSE:CIFree Report) by 74.5% in the fourth quarter, HoldingsChannel.com reports. The fund owned 10,301 shares of the health services provider’s stock after selling 30,116 shares during the quarter. One Capital Management LLC’s holdings in Cigna Group were worth $2,835,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CI. Brighton Jones LLC lifted its holdings in shares of Cigna Group by 9.3% in the 4th quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock valued at $1,032,000 after buying an additional 318 shares during the period. Sivia Capital Partners LLC lifted its holdings in shares of Cigna Group by 10.4% in the 2nd quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock valued at $384,000 after buying an additional 109 shares during the period. NewEdge Advisors LLC lifted its holdings in shares of Cigna Group by 4.5% in the 2nd quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider’s stock valued at $7,347,000 after buying an additional 958 shares during the period. Treasurer of the State of North Carolina lifted its holdings in shares of Cigna Group by 16.6% in the 2nd quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider’s stock valued at $49,204,000 after buying an additional 21,173 shares during the period. Finally, Osterweis Capital Management Inc. acquired a new position in shares of Cigna Group in the 2nd quarter valued at about $163,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Price Performance

NYSE:CI opened at $272.37 on Wednesday. Cigna Group has a 12 month low of $239.51 and a 12 month high of $338.89. The stock has a 50 day moving average of $278.51 and a two-hundred day moving average of $277.06. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. The firm has a market cap of $72.05 billion, a P/E ratio of 11.55, a price-to-earnings-growth ratio of 0.99 and a beta of 0.28.

Cigna Group (NYSE:CIGet Free Report) last posted its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, topping the consensus estimate of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The company had revenue of $68.52 billion during the quarter, compared to analyst estimates of $66.29 billion. During the same period in the previous year, the business earned $6.74 EPS. Cigna Group’s quarterly revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, analysts expect that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be paid a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a yield of 2.3%. The ex-dividend date is Thursday, June 4th. Cigna Group’s payout ratio is 26.45%.

Analyst Ratings Changes

Several equities analysts have recently issued reports on CI shares. The Goldman Sachs Group boosted their price objective on Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a report on Monday, May 4th. Guggenheim boosted their price objective on Cigna Group from $334.00 to $338.00 and gave the company a “buy” rating in a report on Monday, May 4th. Sanford C. Bernstein boosted their price objective on Cigna Group from $358.00 to $371.00 and gave the company an “outperform” rating in a report on Tuesday, May 5th. Truist Financial boosted their price objective on Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a report on Tuesday, February 17th. Finally, Wells Fargo & Company boosted their price objective on Cigna Group from $300.00 to $305.00 and gave the company an “equal weight” rating in a report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $339.50.

View Our Latest Analysis on Cigna Group

Insider Activity

In other news, CEO David Cordani sold 201,878 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the sale, the chief executive officer directly owned 34,337 shares in the company, valued at $10,054,560.34. This represents a 85.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by company insiders.

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Featured Stories

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.